Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic — United States, 2019–2021
Samantha L Williams,Dallas J Smith,Kaitlin Benedict,Jamie R Ahlers,Connie Austin,Rachael Birn,Angel M Carter,Natalie N Christophe,Katie Cibulskas,Paul R Cieslak,Suzanne N Gibbons-Burgener,Michael Gosciminski,Malia J Ireland,Katelyn V Lazenby,Tom Loftus,Kristy Lunquest,Abby A Mathewson,Alyssa D Nguyen,Hanna N Oltean,BreAnne Osborn,Erin M Petro,Danny J Power,Rebecca R Reik,Levi Schlosser,Judi Sedivy,Chad B Smelser,Tom Chiller,Mitsuru Toda,Samantha L. Williams,Dallas J. Smith,Jamie R. Ahlers,Angel M. Carter,Natalie N. Christophe,Paul R. Cieslak,Suzanne N. Gibbons-Burgener,Malia J. Ireland,Katelyn V. Lazenby,Abby A. Mathewson,Alyssa D. Nguyen,Hanna N. Oltean,Erin M. Petro,Danny J. Power,Rebecca R. Reik,Chad B. Smelser
DOI: https://doi.org/10.15585/mmwr.mm7311a2
2024-03-22
MMWR Morbidity and Mortality Weekly Report
Abstract:This report describes trends in coccidioidomycosis, histoplasmosis, and blastomycosis cases during the COVID-19 pandemic.
public, environmental & occupational health